New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 24, 2012
10:25 EDTAGN, VPHM, TWX, RBCN, STR, PVH, LAMR, CTB, BODY, RHIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Outperform from Underperform at CLSA... Body Central (BODY) upgraded to Outperform from Perform at Oppenheimer... Cooper Tire (CTB) upgraded to Buy from Hold at Deutsche Bank... Lamar Advertising (LAMR) upgraded to Outperform from Market Perform at Wells Fargo... PVH Corp. (PVH) upgraded to Overweight from Neutral at Piper Jaffray... Questar (STR) upgraded to Buy from Neutral at UBS... Rubicon (RBCN) upgraded to Neutral from Sell at Goldman... Time Warner (TWX) upgraded to Overweight from Equal Weight at Morgan Stanley... ViroPharma (VPHM) upgraded to Outperform from Market Perform at Wells Fargo... Robert Half (RHI) upgraded to Buy from Neutral at BofA/Merrill.
News For AGN;BODY;CTB;LAMR;PVH;STR;RBCN;TWX;VPHM;RHI From The Last 14 Days
Check below for free stories on AGN;BODY;CTB;LAMR;PVH;STR;RBCN;TWX;VPHM;RHI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 15, 2014
11:13 EDTAGNPerrigo retreats after analyst sees limited potential buyers
Subscribe for More Information
10:00 EDTTWXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Adecogro (AGRO) downgraded to Underperform from Neutral at BofA/Merrill... Campbell Soup (CPB) downgraded to Sell from Neutral at Goldman... Credicorp (BAP) downgraded to Neutral from Overweight at JPMorgan... El Paso Pipeline (EPB) downgraded to Neutral from Buy at Citigroup... Kellogg (K) downgraded to Sell from Neutral at Goldman... Kodiak Oil & Gas (KOG) downgraded to Market Perform from Outperform at BMO Capital... Lexmark (LXK) downgraded at Bernstein... Maxim Integrated (MXIM) downgraded to Equal Weight from Overweight at Barclays... Republic Airways (RJET) downgraded to Underperform from Neutral at BofA/Merrill... Sasol (SSL) downgraded to Neutral from Buy at Citigroup... Time Warner (TWX) downgraded to Equal Weight from Overweight at Evercore.
06:43 EDTTWXTime Warner looks for NBA programming deal renewal, Bloomberg says
Time Warner (TWC) and Disney's (DIS) ESPN are looking to renew the last big U.S. sports agreement with the National Basketball Association that’s up for grabs until 2021, according Reuters, citing people familiar with the talks. Time Warner and Disney, which divvy-up airing the games, pay the league an average total of $930M annually. Reference Link
06:36 EDTTWXNBA seeks to double TV-rights fees from Disney, Time Warner, WSJ reports
Subscribe for More Information
06:06 EDTTWXTime Warner downgraded to Equal Weight from Overweight at Evercore
Subscribe for More Information
July 14, 2014
12:47 EDTAGNAllergan slides question Valeant growth, disclosures, says BMO Capital
Subscribe for More Information
08:13 EDTAGNAllergan reiterates belief that Valeant model unsustainable in new presentation
Subscribe for More Information
08:02 EDTAGNValeant submits HSR filing for proposed acquisition of Allergan
Subscribe for More Information
06:42 EDTTWX'Dawn of the Planet of the Apes' leads box office with $73M opening, WSJ says
Subscribe for More Information
July 11, 2014
16:48 EDTAGNAllergan comments on Pershing Square’s definitive proxy solicitation
Allergan (AGN) provided the following comment in response to the definitive proxy solicitation filed by Pershing Square Capital Management in connection with Pershing Square’s request to call a Special Meeting of Stockholders. At the Special Meeting, if called, Allergan stockholders would be asked to remove a majority of the company’s existing directors in connection with Valeant Pharmaceuticals' (VRX) unsolicited exchange offer to acquire all outstanding common shares of Allergan for 0.83 shares of Valeant common stock and $72.00 in cash, or subject to proration, an amount of cash or a number of Valeant common shares with the implied value set forth in the exchange offer. Under the current Board’s leadership, which includes individuals with significantly more industry experience than Pershing Square’s recommended nominees, Allergan continues to execute on its plan to drive near- and long-term organic growth, enhance its growth prospects and continue generating significant value for all of Allergan’s stockholders. We believe Pershing Square’s attempt to replace a majority of the Allergan Board is a further effort to support Valeant in its bid to acquire Allergan at a grossly inadequate price that substantially undervalues the company and creates significant risks and uncertainties for Allergan stockholders. Valeant has repeatedly failed to address the serious concerns raised by Allergan and important members of the investment community about Valeant’s anemic organic growth driven by unsustainable price increases, among other fundamental business model issues. Allergan has a track record of consistently acting in the best interests of its stockholders and the Board remains confident in the company’s ability to create significantly more value than Valeant’s proposal.
11:54 EDTAGNAbbVie, Shire in active takeover talks, Bloomberg reports
AbbVie (ABBV) and Shire (SHPG) are in active talks about a potential merger after AbbVie raised its takeover offer for a fourth time, Bloomberg reports, citing people with knowledge of the matter. The talks are in the early stage and may not lead to an agreement, sources told Bloomberg. Shares of Shire are up 5%, or $12.04, to $250.65 following the report.
July 10, 2014
07:28 EDTTWXTime Warner CEO says not worried about Warner Bros. financing, Variety reports
Subscribe for More Information
05:50 EDTTWXStocks with implied volatility movement; TWX VHC
Subscribe for More Information
July 9, 2014
18:31 EDTAGNShareholders urge Allergan to make large acquisition, FT reports
Subscribe for More Information
18:21 EDTAGNAllergan CEO seeks sizeable acquisitions, WSJ reports
Subscribe for More Information
14:45 EDTTWXTime Warner says no truth to rumor of M&A talks with Google, WSJ reporter says
Subscribe for More Information
12:52 EDTTWXGasparino says hearing 'buzz' of Google buying Time Warner
Charles Gasparino of Fox Business tweeted ahead of the Sun Valley conference, "I'm now hearing more Google buying time warner buzz than any other company will advise once I get to #sunvalley." Shares of Time Warner are at their highs of the day, up 81c to $71.56.
10:02 EDTTWXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:07 EDTBODYBody Central delists from NASDAQ, moves to OTC Market
Body Central announced that trading of the company's common stock on the NASDAQ Stock Market will be suspended prior to the opening of trading. The company anticipates that its common stock will be immediately eligible for quotation on the OTC Pink Marketplace at the opening of trading under the same symbol. The OTC Pink Marketplace is a market tier operated by OTC Markets Group Inc. for over-the-counter traded companies. As previously disclosed, under the NASDAQ Marketplace Rules, the company was required to obtain stockholder approval, prior to closing, for the issuance of $18M private placement of subordinated secured convertible notes, which was consummated on June 27. However, in order to preserve the financial viability of the company, it was necessary to consummate the Notes transaction before stockholder approval could be obtained. As a result, the company determined to voluntarily delist from the NASDAQ Stock Market. The transition to the OTC Pink Marketplace will not change the company's obligation to file periodic and other reports with the SEC under applicable federal securities laws, and Body Central's shareholders remain owners of the common stock.
06:19 EDTAGNAllergan plans broad restructuring plan, Bloomberg says
Allergan (AGN), the pharmaceutical maker that is being chased by Valeant (VRX) and Bill Ackman’s hedge fund, will shelve unpromising pipeline medicines and revamp management incentives, according to Bloomberg, citing two people with knowledge of the matter. The sources said that the restructuring plan, which is set to be explained during Allergan's upcoming earnings announcement, will also detail companywide cost reductions including some legacy expenses. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use